Alzheimer's disease starts with a sticky protein called amyloid beta that builds up into plaques in the brain, setting off a chain of events that results in brain atrophy and cognitive decline. The new generation of Alzheimer's ...
Apr 3, 2024
0
52
Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.
Mar 8, 2024
0
10
Cerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to six years before diagnosis, according ...
Mar 2, 2024
0
45
Alzheimer's quietly ravages the brain long before symptoms appear and now scientists have new clues about the dominolike sequence of those changes—a potential window to one day intervene.
Feb 22, 2024
0
2
A new research paper titled "GV1001 reduces neurodegeneration and prolongs lifespan in 3xTg-AD mouse model through anti-aging effects" has been published in Aging.
Feb 15, 2024
0
21
UNC School of Medicine researcher Sarah Cohen, Ph.D., and Ian Windham, a former Ph.D. student from the Cohen lab, have made a new discovery about apolipoprotein E (APOE)—the biggest genetic risk factor for late-onset Alzheimer's ...
Feb 9, 2024
0
64
While newly approved drugs for Alzheimer's show some promise for slowing the memory-robbing disease, the current treatments fall far short of being effective at regaining memory. What is needed are more treatment options ...
Feb 1, 2024
0
123
A controversial Alzheimer's drug that was trumpeted as the first to ever treat the cognitive decline associated with the devastating brain disorder has been pulled from the market, its maker Biogen announced Wednesday.
Jan 31, 2024
0
15
Five cases of Alzheimer's disease are believed to have arisen as a result of medical treatments decades earlier, reports a team of UCL and UCLH researchers.
Jan 29, 2024
0
8
The prevailing theory on the causes of Alzheimer's disease indicates that they are related to the abnormal accumulation of two proteins, amyloid-beta (Aβ) and tau, in neuronal tissues, but there are still many unknowns concerning ...
Jan 17, 2024
0
0
